StartsideHPX • FRA
add
Hisamitsu Pharmaceutical Co Inc
Forrige sluttkurs
25,60 €
Dagsintervall
25,80 € - 25,80 €
Årsintervall
21,00 € - 28,80 €
Markedsverdi
364,25 mrd. JPY
Gjennomsnittlig volum
6,00
P/E-tall
-
Utbytte
-
Hovedbørs
TYO
Markedsnyheter
Om
The Hisamitsu Pharmaceutical Co., Inc., headquartered in Saga and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch. Hisamitsu has specialised in transdermal drug delivery system technology since the introduction of its original line of patches in 1903.
Hisamitsu's products under the Salonpas and Bye-Bye Fever brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the U.S Food and Drug Administration. Wikipedia
Grunnlagt
1847
Hovedkvarter
Nettsted
Ansatte
2 759